[6-K] Concord Medical Services Holding Limited Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Concord Medical Services Holdings Limited (NYSE: CCM) filed a Form 6-K to disclose that its Hong Kong–listed subsidiary, Concord Healthcare Group Co., Ltd. (HKSE: 2453.HK), experienced a reduction in the stake held by one of its controlling shareholders. On 20 June 2025, Beijing Concord Medical Technology Co., Ltd. sold 32,800,000 H shares of Concord Healthcare via block trade at HK$6.12 per share, equal to approximately 4.46 % of Concord Healthcare’s issued share capital. The filing reiterates that Concord Healthcare’s H shares were listed on the HKSE on 9 January 2024 and directs investors to the HKSE website for transaction details.

No additional financial results, earnings data or strategic initiatives were reported in this 6-K.

Positive

• Improved share liquidity: The 32.8 million-share block trade increases Concord Healthcare’s public float, potentially enhancing trading depth.

Negative

• Insider selling: A controlling shareholder reduced its stake by 4.46 %, which can be interpreted as weaker insider confidence.
• Lack of disclosed rationale: The filing provides no explanation for the sale, leaving uncertainty for investors regarding future share sales.

Insights

Financial Analyst

TL;DR: 4.46 % insider stake sold; raises modest governance and sentiment questions.

The disposal reduces a controlling shareholder’s stake in Concord Healthcare, suggesting slightly diminished insider commitment, though the seller remains a major holder. At HK$6.12, cash proceeds total roughly HK$200.7 million (US$25.7 million). Liquidity of the H-share float increases, which can aid trading volumes. However, the absence of stated strategic rationale leaves investors to interpret the move cautiously. No impact on Concord Medical’s consolidated operations or cash flow is mentioned, making the event moderately negative in sentiment but not financially material at the CCM level.

Corporate Governance Expert

TL;DR: Block sale trims control but governance structure unchanged—neutral-to-slightly negative.

A 4.46 % reduction does not appear to threaten control, yet it signals willingness of insiders to monetize holdings only 18 months after listing. Investors typically watch such moves for alignment concerns. The filing includes no indication of board changes or voting-rights adjustments, so overall governance architecture remains intact. Transparency is adequate because the trade was promptly disclosed through HKSE and SEC channels.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2025

Commission File Number: 001-34563

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

Room A1-A5 26/F, East Zone, Hanwei Plaza

No. 7 Guanghua Road, Chaoyang District,

Beijing 100020

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F   x                Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

Concord Healthcare Announces Decrease in Shareholding by a Controlling Shareholder

Concord Healthcare Group Co., Ltd. (“Concord Healthcare”), a subsidiary of Concord Medical Services Holdings Limited (the “Company”) (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKSE”) under the stock code 2453.HK, announced that one of its controlling shareholders, Beijing Concord Medical Technology Co., Ltd., disposed a total of 32,800,000 H shares of Concord Healthcare by block trading at the price of HK$6.12 per share on June 20, 2025, representing approximately 4.46% of the total issued shares of Concord Healthcare as of the date of this current report.

The Company previously announced the listing of Concord Healthcare’s H shares on the HKSE on January 9, 2024. The information related to Concord Healthcare’s Transactions on the HKSE is accessible through the HKSE’s website at www.hkexnews.hk.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CONCORD MEDICAL SERVICES HOLDINGS LIMITED
	By:	/s/ Jianyu Yang
	Name:	Jianyu Yang
	Title:	Chairman and Chief Executive Officer

Date: June 20, 2025

FAQ

How many Concord Healthcare shares were sold by the controlling shareholder?

Beijing Concord Medical Technology Co., Ltd. disposed of 32,800,000 H shares.

What percentage of Concord Healthcare’s issued share capital does the sale represent?

The block trade equals approximately 4.46 % of total issued shares.

At what price were the H shares sold?

The sale was executed at HK$6.12 per share on 20 June 2025.

Does the transaction affect Concord Medical Services Holdings Limited’s control over its subsidiary?

The filing does not state any change in overall control; only one controlling shareholder trimmed its position.

Where can investors find further details on the transaction?

Additional information is available on the HKSE website (www.hkexnews.hk) under stock code 2453.HK.